Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19 Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021
Severe a1-antitrypsin deficiency associated with reduced blood pressure and lower plasma triglycerides in the general population Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Inflammation-sensitive plasma proteins are associated with increased incidence of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 629s Year: 2007
Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010
Plasma levels of soluble RAGE are lower in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed? Source: Eur Respir J 2006; 28: Suppl. 50, 331s Year: 2006
L-arginine plasma levels correlate with severity of primary pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004
Elevated pulmonary vascular resistance is associated with increased risk of death in IPF Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019
Decrease in circulating monocyte metalloproteinase-9 content with increasing severity of pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002
Increased plasma fibrinogen could predict frequent exacerbations in asthma Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005
Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003
Serum osteoprotegerin and fibulin-1 levels negatively correlate with DLCO in IPF Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Smoking cessation is associated with a reduction in vWF plasma levels Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Serum leptin – is it associated with levels of airway responsiveness? Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013